Skip to main content
. 2017 Feb 8;105(3):589–599. doi: 10.3945/ajcn.116.139683

TABLE 5.

Glycemic control before and after 6 wk of consumption of a refined grain–based or whole grain–rich diet1

Refined grain Whole grain P 2
n Week 23 ΔWeeks 2–84 n Week 23 ΔWeeks 2–84 β ± SE5 Model 1 Model 2 Model 3
Fasting serum measure
 Glucose, mg/dL 40 91 ± 11 1 (−3, 4) 40 91 ± 10 −2 (−4, 1) −2.0 ± 2.1 0.36 0.47 0.52
 Insulin, μU/mL 40 9.5 (6.4) −0.6 (−1.3, 1.2) 40 8.5 (5.5) −0.8 (−2.3, 0.7) −0.7 ± 0.9 0.41 0.42 0.37
 HOMA-IR 40 2.3 (1.5) 0.02 (−0.4, 0.4) 40 2.4 (1.4) −0.2 (−0.6, 0.2) −0.2 ± 0.3 0.36 0.39 0.35
 QUICKI6 40 0.35 ± 0.04 0 (−0.01, 0.01) 40 0.35 ± 0.03 0.01 (0.001, 0.01) 0.01 ± 0.07 0.26 0.31 0.29
24-h continuous glucose monitoring
 24-h mean, mg/dL 17 97 ± 11 2 (−3, 7) 17 100 ± 10 3 (−4, 10) 2.0 ± 3.8 0.61 0.53 0.62
 24-h CV, % 17 11.1 (9.5) 1.2 (−2.4, 4.8) 17 14.6 (5.1) 0.3 (−4.0, 4.6) 1.5 ± 2.0 0.46 0.42 0.60
 24-h SD, mg/dL 17 10.6 (11.2) 1.7 (−2.2, 5.5) 17 14.9 (5.7) 1.0 (−2.9, 5.0) 1.0 ± 2.4 0.68 0.58 0.77
 AUC, h × mg/dL 17 2333 ± 253 50 (−67, 167) 17 2393 ± 237 71 (−100, 242) 48 ± 92 0.60 0.54 0.62
Oral-glucose-tolerance test
 Matsuda index 13 6.7 ± 3.1 0.2 (−0.7, 1.2) 8 7.4 ± 4.1 −0.9 (−3.2, 1.4) −0.9 ± 0.8 0.28 0.52 0.44
1

There were no significant differences during week 2.

2

Determined with the use of an ANCOVA. Model 1 was adjusted for the baseline value of the outcome; model 2 was adjusted as for model 1 and for age, sex, and baseline BMI; and model 3 was adjusted as for model 2 and for weight change.

3

Values are means ± SDs or medians (IQRs).

4

All values are means (95% CIs).

5

Obtained from model 1 with refined grain as the reference group.

6

QUICKI, quantitative insulin-sensitivity check index.